Palmitic Acid Induces Osteoblastic Differentiation in Vascular Smooth Muscle Cells through ACSL3 and NF-κB, Novel Targets of Eicosapentaenoic Acid

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Kageyama, Aiko ^a   Matsui, Hiroki ^b,c   Ohta, Masahiko ^a   Sambuichi, Keisuke ^a   Kawano, Hiroyuki ^a   Notsu, Tatsuto ^a   Imada, Kazunori ^a   Yokoyama, Tomoyuki ^c   Kurabayashi, Masahiko ^b  

^a MOCHIDA PHARMACEUTICAL CO   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CASPASE 3; CASPASE 7; ICOSAPENTAENOIC ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE; LONG CHAIN FATTY ACID COENZYME A LIGASE 3; MESSENGER RNA; OSTEOPONTIN; PALMITIC ACID; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ARTERY CALCIFICATION; ARTICLE; BMP 2 GENE; CALCIFICATION; CAROTID ATHEROSCLEROSIS; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MINERALIZATION; MSX2 GENE; OSTEOBLAST; OSTEOPONTIN GENE; PROMOTER REGION; SMOOTH MUSCLE FIBER;

AORTA; BONE MORPHOGENETIC PROTEIN 2; CALCINOSIS; CALCIUM; CAROTID ARTERIES; CASPASES; CELL DIFFERENTIATION; CELLS, CULTURED; COENZYME A LIGASES; EICOSAPENTAENOIC ACID; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; MACROPHAGES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; OSTEOBLASTS; OSTEOPONTIN; PALMITIC ACID; PLAQUE, ATHEROSCLEROTIC; PROMOTER REGIONS, GENETIC;

ADENOVIRIDAE;

EID: 84879514705     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068197     Document Type: Article

References (39)

1. Vattikuti R, Towler DA, (2004) Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 286: E686-E696.
2. Abedin M, Tintut Y, Demer LL, (2004) Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24: 1161-1170.
3. Mazzini MJ, Schulze PC, (2006) Proatherogenic pathways leading to vascular calcification. Eur J Radiol 57: 384-389.
4. Shioi A, Nishizawa Y, (2009) Vascular calcification in chronic kidney disease: pathogenesis and clinical implications. J Ren Nutr 19: 78-81.
5. Hruska KA, Mathew S, Saab G, (2005) Bone morphogenetic proteins in vascular calcification. Circ Res 97: 105-114.
6. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, et al. (1999) Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 100: 2168-2176.
7. Fagot-Campagna A, Balkau B, Simon D, Warnet JM, Claude JR, et al. (1998) High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study. Int J Epidemiol 27: 808-813.
8. Boden G, (2008) Obesity and free fatty acids (FFA). Endocrinol Metab Clin North Am 37: 635-646.
9. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD, (1988) Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37: 1020-1024.
10. Håversen L, Danielsson KN, Fogelstrand L, Wiklund O, (2009) Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis 202: 382-393.
11. Ting TC, Miyazaki-Anzai S, Masuda M, Levi M, Demer LL, et al. (2011) Increased lipogenesis and stearate accelerate vascular calcification in calcifying vascular cells. J Biol Chem 286: 23938-23949.
12. Masuda M, Ting TC, Levi M, Saunders SJ, Miyazaki-Anzai S, et al. (2012) Activating transcription factor 4 regulates stearate-induced vascular calcification. J Lipid Res 53: 1543-1552.
13. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, et al. (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369: 1090-1098.
14. Schlemmer CK, Coetzer H, Claassen N, Kruger MC, Rademeyer C, et al. (1998) Ectopic calcification of rat aortas and kidneys is reduced with n-3 fatty acid supplementation. Prostaglandins Leukot Essent Fatty Acids 59: 221-227.
15. Burgess NA, Reynolds TM, Williams N, Pathy A, Smith S, (1995) Evaluation of four animal models of intrarenal calcium deposition and assessment of the influence of dietary supplementation with essential fatty acids on calcification. Urol Res 23: 239-242.
16. Kanai S, Uto K, Honda K, Hagiwara N, Oda H, (2011) Eicosapentaenoic acid reduces warfarin-induced arterial calcification in rats. Atherosclerosis 215: 43-51.
17. Abedin M, Lim J, Tang TB, Park D, Demer LL, et al. (2006) N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-γ pathways. Circ Res 98: 727-729.
18. Heine-Bröring RC, Brouwer IA, Proença RV, van Rooij FJ, Hofman A, et al. (2010) Intake of fish and marine n-3 fatty acids in relation to coronary calcification: the Rotterdam Study. Am J Clin Nutr 91: 1317-1323.
19. Staiger H, Staiger K, Stefan N, Wahl HG, Machicao F, et al. (2004) Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. Diabetes 53: 3209-3216.
20. Staiger K, Staiger H, Weigert C, Haas C, Häring HU, et al. (2006) Saturated, but not unsaturated, fatty acids induce apoptosis of human coronary artery endothelial cells via nuclear factor-κB activation. Diabetes 55: 3121-3126.
21. Matsui H, Yokoyama T, Sekiguchi K, Iijima D, Sunaga H, et al. (2012) Stearoyl-CoA desaturase-1 (SCD1) augments saturated fatty acid-induced lipid accumulation and inhibits apoptosis in cardiac myocytes. PLoS One 7: e33283.
22. Carlsson M, Wessman Y, Almgren P, Groop L, (2000) High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 20: 1588-1594.
23. Pirro M, Mauriège P, Tchernof A, Cantin B, Dagenais GR, et al. (2002) Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Quèbec Cardiovascular Study. Atherosclerosis 160: 377-384.
24. Roden M, (2006) Mechanisms of Disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2: 335-348.
25. Libby P, Okamoto Y, Rocha VZ, Folco E, (2010) Inflammation in atherosclerosis: transition from theory to practice. Circ J 74: 213-220.
26. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, et al. (2000) High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945.
27. Mugabo Y, Mukaneza Y, Renier G, (2011) Palmitate induces C-reactive protein expression in human aortic endothelial cells. Relevance to fatty acid-induced endothelial dysfunction. Metabolism 60: 640-648.
28. Kato T, Shimano H, Yamamoto T, Ishikawa M, Kumadaki S, et al. (2008) Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic islets. Diabetes 57: 2382-2392.
29. Itoh M, Suganami T, Satoh N, Tanimoto-Koyama K, Yuan X, et al. (2007) Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol 27: 1918-1925.
30. Askari B, Kanter JE, Sherrid AM, Golej DL, Bender AT, et al. (2007) Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-γ-independent mechanism in human arterial smooth muscle cells and macrophages. Diabetes 56: 1143-1152.
31. Lockridge JB, Sailors ML, Durgan DJ, Egbejimi O, Jeong WJ, et al. (2008) Bioinformatic profiling of the transcriptional response of adult rat cardiomyocytes to distinct fatty acids. J Lipid Res 49: 1395-1408.
32. Mashek DG, Bornfeldt KE, Coleman RA, Berger J, Bernlohr DA, et al. (2004) Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. J Lipid Res 45: 1958-1961.
33. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, et al. (2001) Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 89: 1147-1154.
34. Speer MY, McKee MD, Guldberg RE, Liaw L, Yang HY, et al. (2002) Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 196: 1047-1055.
35. Csiszar A, Smith KE, Koller A, Kaley G, Edwards JG, et al. (2005) Regulation of bone morphogenetic protein-2 expression in endothelial cells: role of nuclear factor-κB activation by tumor necrosis factor-α, H2O2, and high intravascular pressure. Circulation 111: 2364-2372.
36. Weigert C, Brodbeck K, Staiger H, Kausch C, Machicao F, et al. (2004) Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-κB. J Biol Chem 279: 23942-23952.
37. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, et al. (2004) Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15: 2857-2867.
38. Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM, (2011) Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 109: 697-711.
39. Schwarz KB, (1996) Oxidative stress during viral infection: a review. Free Radic Biol Med 21: 641-649.